Organic Genetics
PrivateLast Round
Seed
Nov 21, 2022
Total Funding Raised
$3.08M
Company Overview
Organic Genetics is a biotechnology company that develops and produces medicinal cannabis products for the treatment of chronic illnesses and pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Organic Genetics Comparables
Compare Organic Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ora Pharm | 88% | |
| Puro New Zealand | 85% | |
| Helius Therapeutics | 84% |
Organic Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 21, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 122% MoM.
- Jun 1, 2025
Monthly visitors increased 251% MoM.
Organic Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Organic Genetics's valuation, stock price, and market status.
Is Organic Genetics a public or private company?
Organic Genetics is a private company.
What is the current stock price of Organic Genetics?
Organic Genetics is a private company with no public stock price. Caplight tracks Organic Genetics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Organic Genetics worth (valuation)?
Valuation information for Organic Genetics is not publicly available.
Can I buy Organic Genetics stock?
Organic Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Organic Genetics's last funding round?
Organic Genetics's most recent funding round was Seed on November 21, 2022.
Who are the main investors in Organic Genetics?
Investor information for Organic Genetics is not publicly disclosed.
Will Organic Genetics IPO soon?
No public IPO plans have been announced for Organic Genetics.
How can I track Organic Genetics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Organic Genetics's secondary market activity and sign up for updates.